돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 25434생성일: 2026년 10월 25일

Pyridine → N-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilanylethoxymethyl)-1H-indazol-5-yl]-2-methylsulfonylbenzenesulfonamide

https://huagongshe.com/reaction/25434

반응식

참여 물질

역할이름HCID투입량
반응물PyridineHCID 1049—
반응물2-Methanesulfonylbenzene-1-sulfonyl chlorideHCID 2735178—
반응물3-(1H-benzimidazol-2-yl)-5-amino-1-{[2-(trimethylsilyl)ethoxy]methyl}indazoleHCID 136336345—
용매Cyclohexane ethylacetateHCID 21867204—
생성물N-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilanylethoxymethyl)-1H-indazol-5-yl]-2-methylsulfonylbenzenesulfonamideHCID 13562193494%

반응 단계

N-[3-(1H-Benzimidazol-2-yl)-1-(2-trimethylsilanylethoxymethyl)-1H-indazol-5-yl]-2-methylsulfonylbenzenesulfonamide can be obtained as described in Example 2 from 130 mg of 3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilanylethoxymethyl)-1H-indazol-5-ylamine, 5 ml of pyridine and 87 mg of 2-methylsulfonylbenzenesulfonyl chloride. 192 mg of N-[3-(1H-benzimidazol-2-yl)-1-(2-trimethylsilanylethoxymethyl)-1H-indazol-5-yl]-2-methylsulfonylbenzenesulfonamide are thus obtained in the form of an orange lac (Rf=0.53, silica gel thin layer chromatography, eluent: cyclohexane/ethyl acetate (50/50 by volume), mass analysis: Cl: m/z 598 (M+H)+.)

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06858638B2
출처 데이터셋uspto-grants-2005_02
ORD IDord-2f8483c8059149e2b9e120ca1934177b
출처 메모uspto-grants-2005_02